Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tear film stabilization via osmoprotective effects refers to the use of osmoprotectants to maintain tear film integrity under hyperosmolar conditions. Key molecules include L-carnitine, erythritol, betaine, glycerol, and trehalose, which protect ocular surface cells from osmotic stress, reduce inflammation, and improve tear film stability. These agents are commonly used in artificial tears and contact lens solutions to manage dry eye disease and related disorders.
Osmoprotectants enter ocular surface epithelial cells via transporters, balancing intracellular osmolality without disrupting normal cellular metabolism. They reduce water loss from the tear film by increasing viscosity or forming protective layers on the ocular surface. Examples include glycerol acting as a humectant to retain moisture and stabilize cell membranes against shrinkage due to high osmolarity, and trehalose preserving corneal/conjunctival cell viability during desiccation by delaying water evaporation from the tear film.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tear Film Stabilization (Osmoprotective Effect) (TFS-OE).